Metraipolis › archive › dc_af76ce998c98
Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical… — Europe PMC PMID:41096574
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41096574
- DOI
- 10.3390/ijms26199305
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:23:43.699Z
- SHA-256 of the archived text
970abc268b37801a018a6f5acea2511c280f5c2f18812b6668c56dbd2a0ed865- Stable URL of this page
https://metraipolis.com/documento/dc_af76ce998c98
How to cite
Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical… — Europe PMC PMID:41096574 — Europe PMC (en), https://europepmc.org/article/MED/41096574 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af76ce998c98 (Metraipolis archive dc_af76ce998c98, sha256 970abc268b37801a018a6f5acea2511c280f5c2f18812b6668c56dbd2a0ed865)
BibTeX
@misc{dcaf76ce998c98,
title = {Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical… — Europe PMC PMID:41096574},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41096574},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af76ce998c98; sha256 970abc268b37801a018a6f5acea2511c280f5c2f18812b6668c56dbd2a0ed865},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41096574. Agents can read the archived copy with the MCP tool read_document.